An ELISA for plasma retinol-binding protein using monoclonal and polyclonal antibodies: Plasma variation in normal and insulin resistant subjects

Clinical Biochemistry

Volumn 40, Issue 11, 2007, Pages 828-834

  Lewis, John G ^a   Shand, Brett I ^b   Frampton, Chris M ^b   Elder, Peter A ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Biovariation; Diurnal variation; Insulin resistance; Plasma; Retinol binding protein

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RETINOL BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; PATIENT CODING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADULT; ANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC DISEASES; RETINOL-BINDING PROTEINS; TIME FACTORS;

EID: 34250696062     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.03.021     Document Type: Article

References (22)

1. Blaner W.S. Retinol-binding protein: the serum transport protein for vitamin A. Endocr. Rev. 10 (1989) 308-316
2. Newcomer M.E., and Ong D.E. Plasma retinol binding protein: structure and function of the prototype lipocalin. Biochim. Biophys. Acta 1482 (2000) 57-64
3. Raghu P., and Sivakumar B. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. Biochim. Biophys. Acta 1703 (2004) 1-9
4. Baeten J.M., Richardson B.A., Bankson D.D., Wener M.H., Kreiss J.K., Lavreys L., et al. Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response. Am. J. Clin. Nutr. 79 (2004) 218-225
5. Wagnerberger S., Schäfer C., Bode C., and Parlesak A. Saturation of retinol-binding protein correlates closely to the severity of alcohol-induced liver disease. Alcohol 38 (2006) 37-43
6. Sousa M.M., Norden A.G.W., Jacobsen C., Willnow T.E., Christensen E.I., Thakker R.V., et al. Evidence for the role of megalin in renal uptake of transthyretin. J. Biol. Chem. 275 (2000) 38176-38181
7. Chinen R., Camara N.O.S., Nishida S., Silva M.S., Rodrigues D.A., Pereira A.B., et al. Determination of renal function in long-term heart transplant patients by measurement of urinary retinol-binding protein levels. Braz. J. Med. Biol. Res. 39 (2006) 1305-1313
8. Gavrilov V., Yermiahu T., and Gorodischer R. Renal pathology and retinol status in multiple myeloma patients. Kidney Int. 69 (2006) 173-177
9. Breustedt D.A., Schönfeld D.L., and Skerra A. Comparative ligand-binding analysis of ten human lipocalins. Biochim. Biophys. Acta 1764 (2006) 161-173
10. Wojnar P., Lechner M., Merschak P., and Redl B. Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display. J. Biol. Chem. 276 (2001) 20206-20212
11. Redondo C., Burke B.J., and Findlay J.B.C. The retinol-binding protein system: a potential paradigm for steroid-binding globulins?. Horm. Metab. Res. 38 (2006) 269-278
12. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 (2005) 356-362
13. Graham T.E., Yang Q., Blüher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354 (2006) 2552-2563
14. Erhardt J.G., Estes J.E., Pfeiffer C.M., Biesalski H.K., and Craft N.E. Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique. J. Nutr. 134 (2004) 3127-3132
15. Lewis J.G., Clifford J.K., and Elder P.A. Monoclonal antibodies to pregnanediol-3-glucuronide: application to a direct enzyme-linked immunosorbent assay of urine. Steroids 55 (1990) 314-318
16. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
17. Barassi A., Pallotti F., and Melzi d'Eril G.V. Biological variation of procalcitonin in healthy individuals. Clin. Chem. 50 (2004) 1878
18. Molyneux S.L., Florkowski C.M., Lever M., and George P.M. Biological variation of coenzyme Q10. Clin. Chem. 51 (2005) 455-457
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostatsis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
20. Tsutsumi C., Okuno M., Tannous L., Piantedosi R., Allan M., Goodman D.W.S., et al. Retinoids and retinol-binding protein expression in rat adipocytes. J. Biol. Chem. 267 (1992) 1805-1810
21. Soprano D.R., Soprano K.J., and Goodman D.W.S. Retinol-binding protein messenger RNA levels in the liver and extrahepatic tissues of the rat. J. Lipid Res. 27 (1986) 166-171
22. Janke J., Engeli S., Boschmann M., Adams F., Böhnke J., Luft F.C., et al. Retinol-binding protein 4 in human obesity. Diabetes 55 (2006) 2805-2810